--Newly acquired novel psychedelic molecules diversify Cybin’s development portfolio, providing access to multiple future indications-- --Adelia brings a range of...
Commercial Launch of Ergonomix2 Planned for 2021Approval Accelerates Path to Europe for Motiva MiaPre-Commercial European Mia Procedures to Begin in...
All 104 Operating Communities have been registered and confirmedDALLAS, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the...
Program strategy and prioritization supports projection of available capital through 2021BASKING RIDGE, N.J., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Caladrius...
SAN CARLOS, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (Nasdaq: BCDA)(BioCardia or the “Company”) today announces that it anticipates...
BOSTON, Dec. 14, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
LOS ANGELES, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Canadian Life Science (“CLS”), a...
Service Availability is Expected in January 2021 MOUNTAIN VIEW, CA and REHOVOT, ISRAEL, Dec. 14, 2020 (GLOBE NEWSWIRE) -- via...
-Funding from the Bill & Melinda Gates Foundation will support research to enable CRISPR/Cas9-based therapies for HIV that can benefit...
OREM, Utah, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research have added new PacBio Sequel II &...
Record Quarter with Gross Revenue of $41.3 MillionAdjusted EBITDA Improves for the Sixth Consecutive Quarter OTTAWA, Dec. 14, 2020 (GLOBE...
-- Former Genzyme and Lilly executive brings broad industry expertise as Oncorus advances its viral immunotherapies pipeline and plans strategic...
Press Release Hørsholm, Denmark (14 December 2020) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced that...
Dr. Bobbi Peterson has not let being diagnosed with cancer hold her back. The celebrity doctor launches ThristRX and documents...
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines...
Additional Data from FORTITUDE-ALS Support Rationale and Design for COURAGE-ALS, A Planned Phase 3 Clinical Trial of Reldesemtiv in Patients with...
SAN JOSE, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”)...
SEATTLE, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing...
Event will focus on CVL-865, the Phase 2 GABA Positive Allosteric Modulator, and include an overview of key preclinical programs...